TMO - Thermo Fisher Scientific - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8835561023
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts. Web URL: https://www.thermofisher.com
Drawdown (Underwater) Chart
TMO Stock Overview
Market Cap in USD | 236,933m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 1978-01-13 |
TMO Stock Ratings
Growth 5y | 69.6 |
Fundamental | 47.0 |
Dividend | 13.3 |
Rel. Performance vs Sector | -0.33 |
Analysts | 4.21/5 |
Fair Price Momentum | 614.69 USD |
Fair Price DCF | 520.04 USD |
TMO Dividends
Dividend Yield 12m | 0.25% |
Yield on Cost 5y | 0.53% |
Dividends CAGR 5y | 13.00% |
Payout Consistency | 36.2% |
TMO Growth Ratios
Growth 12m | 20.39% |
Growth Correlation 12m | 84% |
Growth Correlation 3m | 64% |
CAGR 5y | 15.90% |
CAGR/Mean DD 5y | 1.38 |
Sharpe Ratio 12m | 0.73 |
Alpha vs SP500 12m | -6.82 |
Beta vs SP500 5y weekly | 0.74 |
ValueRay RSI | 26.40 |
Volatility GJR Garch 1y | 19.66% |
Price / SMA 50 | -1.71% |
Price / SMA 200 | 4.35% |
Current Volume | 871.5k |
Average Volume 20d | 1219.5k |
External Links for TMO Stock
News
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
What is the price of TMO stocks?
As of October 05, 2024, the stock is trading at USD 598.61 with a total of 871,514 shares traded.
Over the past week, the price has changed by -2.57%, over one month by -2.11%, over three months by +10.90% and over the past year by +20.98%.
As of October 05, 2024, the stock is trading at USD 598.61 with a total of 871,514 shares traded.
Over the past week, the price has changed by -2.57%, over one month by -2.11%, over three months by +10.90% and over the past year by +20.98%.
What are the forecast for TMO stock price target?
According to ValueRays Forecast Model, TMO Thermo Fisher Scientific will be worth about 672.2 in October 2025. The stock is currently trading at 598.61. This means that the stock has a potential upside of +12.29%.
According to ValueRays Forecast Model, TMO Thermo Fisher Scientific will be worth about 672.2 in October 2025. The stock is currently trading at 598.61. This means that the stock has a potential upside of +12.29%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 643.9 | 7.57 |
Analysts Target Price | 601.9 | 0.55 |
ValueRay Target Price | 672.2 | 12.3 |